Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-Controlled, Parallel-Group Trial Evaluating an AI-Guided Microbiome-Targeted Nutritional Intervention for Weight Loss in Adults With Overweight or Obesity Without Prediabetes or Diabetes: The AIM-WEIGHT Trial

NCT07736547 is registered in ClinicalTrials.gov with Varol TUNALI as lead sponsor.

NCT NCT07736547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07736547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-Controlled, Parallel-Group Trial Evaluating an AI-Guided Microbiome-Targeted Nutritional Intervention for Weight Loss in Adults With Overweight or Obesity Without Prediabetes or Diabetes: The AIM-WEIGHT Trial
Lead sponsor
Varol TUNALI
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
July 1, 2026
Completion date
June 30, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overweight (bmi > 25), overweight (without type 2 diabetes) with weight-related comorbidities